Advertisement
Screener

SEER, INC. (SEER) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

SEER, INC. Operating Cash Flow

SEER, INC. (SEER) reported Operating Cash Flow of -$25.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-11

  • SEER, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.57M.
  • SEER, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$15.44M.
  • SEER, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$10.81M.
  • SEER, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$7.57M.
  • SEER, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$44.45M.
  • SEER, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$46.11M.
  • SEER, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$59.06M.
  • SEER, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$60.78M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2026-06-30-$9.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$25.01M
10-Q · filed 2026-08-11
-$35.81M
derived: sum of 3 quarters · filed 2026-08-11
-$43.38M
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$15.44M
10-Q · filed 2026-05-13
-$26.24M
derived: sum of 2 quarters · filed 2026-05-13
-$33.81M
derived: sum of 3 quarters · filed 2026-05-13
-$48.47M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31-$10.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$18.37M
derived: sum of 2 quarters · filed 2026-03-02
-$33.03M
derived: sum of 3 quarters · filed 2026-08-11
-$44.45M
10-K · filed 2026-03-02
2025-09-30-$7.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$22.22M
derived: sum of 2 quarters · filed 2026-08-11
-$33.64M
10-Q · filed 2025-11-06
-$45.10M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30-$14.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11
-$26.07M
10-Q · filed 2026-08-11
-$37.53M
derived: sum of 3 quarters · filed 2026-08-11
-$51.66M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31-$11.42M
10-Q · filed 2026-05-13
-$22.87M
derived: sum of 2 quarters · filed 2026-05-13
-$37.00M
derived: sum of 3 quarters · filed 2026-05-13
-$47.07M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$11.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$25.58M
derived: sum of 2 quarters · filed 2026-03-02
-$35.65M
derived: sum of 3 quarters · filed 2026-03-02
-$46.11M
10-K · filed 2026-03-02
2024-09-30-$14.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
-$24.20M
derived: sum of 2 quarters · filed 2025-11-06
-$34.65M
10-Q · filed 2025-11-06
-$44.84M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$10.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$20.52M
10-Q · filed 2025-08-06
-$30.71M
derived: sum of 3 quarters · filed 2025-08-06
-$45.13M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31-$10.46M
10-Q · filed 2025-05-13
-$20.65M
derived: sum of 2 quarters · filed 2025-05-13
-$35.06M
derived: sum of 3 quarters · filed 2025-05-13
-$50.19M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$10.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
-$24.60M
derived: sum of 2 quarters · filed 2025-03-03
-$39.73M
derived: sum of 3 quarters · filed 2025-03-03
-$59.06M
10-K · filed 2025-03-03
2023-09-30-$14.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$29.54M
derived: sum of 2 quarters · filed 2024-11-06
-$48.88M
10-Q · filed 2024-11-06
-$63.13M
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30-$15.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$34.46M
10-Q · filed 2024-08-08
-$48.72M
derived: sum of 3 quarters · filed 2024-08-08
-$62.09M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$19.33M
10-Q · filed 2024-05-08
-$33.59M
derived: sum of 2 quarters · filed 2024-05-08
-$46.96M
derived: sum of 3 quarters · filed 2024-05-08
-$60.96M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31-$14.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04
-$27.63M
derived: sum of 2 quarters · filed 2024-03-04
-$41.63M
derived: sum of 3 quarters · filed 2024-03-04
-$60.78M
10-K · filed 2024-03-04
2022-09-30-$13.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$27.37M
derived: sum of 2 quarters · filed 2023-11-07
-$46.52M
10-Q · filed 2023-11-07
-$58.89M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$14.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$33.15M
10-Q · filed 2023-08-08
-$45.52M
derived: sum of 3 quarters · filed 2023-08-08
-$54.28M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31-$19.15M
10-Q · filed 2023-05-09
-$31.52M
derived: sum of 2 quarters · filed 2023-05-09
-$40.28M
derived: sum of 3 quarters · filed 2023-05-09
-$50.63M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$12.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
-$21.13M
derived: sum of 2 quarters · filed 2023-03-06
-$31.48M
derived: sum of 3 quarters · filed 2023-03-06
-$46.35M
10-K · filed 2023-03-06
2021-09-30-$8.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$19.11M
derived: sum of 2 quarters · filed 2022-11-08
-$33.98M
10-Q · filed 2022-11-08
-$39.46M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$10.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$25.22M
10-Q · filed 2022-08-09
-$30.71M
derived: sum of 3 quarters · filed 2022-08-09
-$36.20M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31-$14.87M
10-Q · filed 2022-05-06
-$20.36M
derived: sum of 2 quarters · filed 2022-05-06
-$25.85M
derived: sum of 3 quarters · filed 2022-05-06
-$30.63M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31-$5.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$10.97M
derived: sum of 2 quarters · filed 2022-03-01
-$15.75M
derived: sum of 3 quarters · filed 2022-03-01
-$20.83M
10-K · filed 2022-03-01
2020-09-30-$5.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$10.27M
derived: sum of 2 quarters · filed 2021-11-09
-$15.34M
10-Q · filed 2021-11-09
2020-06-30-$4.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$9.85M
10-Q · filed 2021-08-12
2020-03-31-$5.07M
10-Q · filed 2021-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
Precipio, Inc. (PRPO)United States$0.043B-36.70
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15